Europe - FRA:RDEB - GB00B2B0DG97 - Common Stock
The current stock price of RDEB.DE is 35.64 EUR. In the past month the price decreased by -8.99%. In the past year, price decreased by -15.7%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WKL.AS | WOLTERS KLUWER | 17.62 | 21.75B | ||
| WOSB.DE | WOLTERS KLUWER | 17.64 | 21.78B | ||
| BVI.PA | BUREAU VERITAS SA | 20.33 | 12.83B | ||
| ARCAD.AS | ARCADIS NV | 24.35 | 3.39B | ||
| TNXT.MI | TINEXTA SPA | 113.54 | 696.82M | ||
| ASY.PA | ASSYSTEM | 80.77 | 658.14M | ||
| AAA.PA | ALAN ALLMAN ASSOCIATES | N/A | 195.07M | ||
| BDT.DE | BERTRANDT AG | N/A | 192.05M | ||
| AVTX.AS | AVANTIUM | N/A | 163.80M | ||
| MARE.MI | MARE ENGINEERING GROUP SPA | N/A | 79.87M | ||
| CORE.MI | ALLCORE SPA | 16.5 | 19.89M | ||
| SEC.PA | SODITECH INGENIERIE | 15.74 | 12.10M |
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. The firm operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment helps researchers and healthcare professionals advance science and improve health outcomes by combining high-quality scientific and medical information. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions.
RELX PLC
1-3 Strand
London GB
Employees: 34580
Phone: 442071665777
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. The firm operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment helps researchers and healthcare professionals advance science and improve health outcomes by combining high-quality scientific and medical information. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions.
The current stock price of RDEB.DE is 35.64 EUR. The price decreased by -2.78% in the last trading session.
RELX PLC (RDEB.DE) has a dividend yield of 1.94%. The yearly dividend amount is currently 0.68.
RDEB.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
RDEB.DE stock is listed on the Deutsche Boerse Ag exchange.
RELX PLC (RDEB.DE) operates in the Industrials sector and the Professional Services industry.
RELX PLC (RDEB.DE) currently has 34580 employees.
ChartMill assigns a fundamental rating of 6 / 10 to RDEB.DE. RDEB.DE scores excellent on profitability, but there are some minor concerns on its financial health.
Over the last trailing twelve months RDEB.DE reported a non-GAAP Earnings per Share(EPS) of 1.17. The EPS increased by 3.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.19% | ||
| ROA | 13.44% | ||
| ROE | 88.3% | ||
| Debt/Equity | 2.57 |
23 analysts have analysed RDEB.DE and the average price target is 47.72 EUR. This implies a price increase of 33.89% is expected in the next year compared to the current price of 35.64.
For the next year, analysts expect an EPS growth of 7.01% and a revenue growth 2.07% for RDEB.DE